Questions and answers | Overall (n = 205) | Sub-group by the number of MS patients under care | P value | |||
---|---|---|---|---|---|---|
Group 1: 1–3 patients (n = 69) | Group 2: 4–9 patients (n = 58) | Group 3: ≥10 patients (n = 78) | Group comparison* | Trend test† | ||
Question 1: Do any of the following constitute a clinical relapse in your practice (in the absence of comorbidities, such as acute infection)? | ||||||
a. New/worsening symptoms lasting > 24 h, no neurological exam performed, n (%) | 98 (47.8) | 29 (42.0) | 31 (53.4) | 38 (48.7) | 0.199a 0.416b 0.585c | 0.437 |
b. New/worsening symptoms lasting > 24 h, no change in neurological exam, n (%) | 106 (51.7) | 29 (42.0) | 34 (58.6) | 43 (55.1) | 0.063a 0.113b 0.684c | 0.122 |
c. New/worsening symptoms lasting > 24 h and worsening neurological exam, n (%) | 201 (98.0) | 67 (97.1) | 57 (98.3) | 77 (98.7) | 0.664a 0.489b 0.832c | 0.483 |
Question 2: In a patient presenting with a clinical relapse based on your definition of a relapse, do you usually order an MRI scan? | ||||||
Yes, n (%) | 205 (100.0) | 69 (100.0) | 58 (100.0) | 78 (100.0) | – | – |
Question 3: Does the appearance of new asymptomatic MRI activity constitute the equivalent of a clinical relapse? | ||||||
Yes, n (%) | 130 (63.4) | 43 (62.3) | 38 (65.5) | 49 (62.8) | 0.709a 0.950b 0.746c | 0.960 |